Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Graziella di Grezia
With
Link Campus University
University of Campania Luigi Vanvitelli
The study of CUP syndrome was conducted with MRI, but we propose the study with CEM
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Age: Patients aged 18 years or older.
Diagnosis of CUP: Patients with a clinical diagnosis of Cancer of Unknown Primary (CUP) syndrome.
Suspected Breast Malignancy: Patients with clinical or imaging suspicion of a primary breast malignancy.
Informed Consent: Patients who are able to provide informed consent to participate in the study.
Presence of Breast Tissue: Female or transgender patients with breast tissue eligible for Contrast-Enhanced Mammography (CEM).
You may not be if
Confirmed Primary Tumor: Patients with a confirmed primary tumor identified in an organ other than the breast.
Contraindications to Contrast Agents: Patients with contraindications to the use of iodinated contrast agents (e.g., severe allergic reactions to contrast).
Severe Renal Impairment: Patients with severe renal impairment (eGFR \< 30 mL/min/1.73 m²) who cannot safely receive contrast agents.
Pregnancy or Breastfeeding: Pregnant or breastfeeding women, as contrast administration may be harmful to the fetus or neonate.
Severe Medical Conditions: Patients with severe medical conditions that may compromise their participation or safety in the study.
Clareo Health | Contrast Enhanced Mammography in the Evaluation of Cancer of Unknown Primary Syndrome
